admin Share This! FacebookTwitterPinterestLinkedIn Investing News Eli Lilly Buys DICE Therapeutics for $2.4 Billion June 20, 202380 Views1 Min Read Eli Lilly agreed to buy DICE Therapeutics for $2.4 billion. The deal values DICE shares at an almost 40% premium from Friday’s close. You may also like Investing News D.E. Shaw, Mantle Ridge zero in on key fixes to build shareholder value at Air Products 3 hours ago Investing News How Credit Rating Risk Affects Corporate Bonds 5 hours ago Investing News Is a Current Account Deficit Good or Bad for the Economy? 8 hours ago Markets Fall at Midday, Pulled Lower by Energy Stocks Mortgage Rates Mostly Flat, Though Jumbo 30-Year Average Revisits Recent High Share This! FacebookTwitterPinterestLinkedIn Newsletter NavigationInvesting News Market Insider Stock Market Stocks to buy Stocks to sell Dividend Stocks Trader Talk Videos Privacy Policy DMCA / Copyrights Disclaimer Terms and Conditions Disclaimer Whitelist Us
Investing News D.E. Shaw, Mantle Ridge zero in on key fixes to build shareholder value at Air Products 3 hours ago